Bandingkan Harga & Kinerja Kalbe Farma Tbk (KLBF) vs Mizuho Leasing Indonesia Tbk. (VRNA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kalbe Farma Tbk dan Mizuho Leasing Indonesia Tbk.: Kalbe Farma Tbk diperdagangkan di Rp735 (kapitalisasi pasar 35,34 T, volume 24 jam 108,3 jt), sedangkan Mizuho Leasing Indonesia Tbk. diperdagangkan di Rp91 (kapitalisasi pasar 534,61 M, volume 24 jam 3,04 jt). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 66,1× kapitalisasi pasar Mizuho Leasing Indonesia Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (108,3 jt vs 3,04 jt). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | VRNA | |
|---|---|---|
Kapitalisasi Pasar | 35,34 T | 534,61 M |
Volume | 108,3 jt | 3,04 jt |
Lot | 1,08 jt | 30,36 rb |
Perputaran | 80,02 M | 276,96 jt |
Harga Rata-rata | 738,89 | 91,21 |
Nilai Transaksi | 80,02 M | 276,96 jt |
Harga Ekuilibrium Indikatif | 735 | 91 |
Volume Ekuilibrium Indikatif | 59,74 rb | 8,99 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →Tentang Mizuho Leasing Indonesia Tbk.
PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.
Selengkapnya di halaman VRNA →
